Introduction
The increasing incidence of severe fungal infections resulting from the prolonged use of immunosuppressive and chemotherapeutic drugs has led to a parallel increase in the use of antifungal agents. One such agent, 5-fluorocytosine (5-FC), is an effective oral antifungal agent with few reported toxic side effects. However, there has been comparatively little experience with this drug which is excreted unchanged almost entirely by the kidney (Koechlin et al, 1966; Wade and Sudlow, 1972) . Information about blood and urine 5-FC levels is partioularly important when renal function is inpaired or when high iblood levels are required to achieve a therapeutic effect.
Satisfactory microbiological (Shadomy, 1969) and chemical (Wade and Sudlow, 1972) methods for the assay of 5-FC have been described, but these are not simple or quick. This paper describes a rapid and sensitive microbiological assay for 5-FC in blood and urine based on that of Faine and Knight (1968) Plates were held at 4'C for a month before being discarded. The evening before setting up an assay sufficient colonies weire removed from the nutrient agar plate to make a suspension containing about 1 x 101 organisms/ml in 5 ml of normal saline. A 2-ml sample of this suspension was added to 400 ml of a 50/, glucose/Difco nutrient broth in a 1-litre flask which was plugged with cotton-wool to allow escape of gas during incubation. After overnight incubation at 37°C on a shaker the number of organisms/ml were counted using a 1: 1,000 dilution and a Neubauer counting chamber. Budding organisms were counted as two. Based on the bacterial count a measured volume of the overnight culture containing about 1010 candida was centrifuged. The supernatant was removed and the deposit of C. albicans suspended in 350 ml of the working glucose/ YNB medium. A 4-ml sample of the suspension was mixed with 1 ml of the diluted, autoclaved zero standard and adjusted by dropwise addition of a pH 7-10 Sorensons phospha-te buffer to a final pH between 5-95 and 6 05. The amount of buffer required for the bulk suspension was calculated from this. The buffer was added and the volume made up to 400 ml with medium. The final concentration of C. albicans in this suspension was about 2-5 x 107 organisms/ml. Assay Procedure.-One ml of the diluted standard, control, or test sera and 4 ml of the prepared candida suspension were mixed in a sterile McCartney bottle. All estimations were carried out in triplicate. Each assay included five control bottles without drug and six bottles containing 2 ig/ml 5-FC standard which were used to monitor the fall in pH of the medium during incubation. The pH of duplicate control samples was read immeditately to esitaiblish the sitarting pH, which should be 6-00 + 0 05 pH units. The remaining bottles were incubated at 37'C on a shaker until a pH of about 3-2 units was reached in the 2 ucg /ml standard (usuallv about three and a half hours). The fall in pH in the 2 ,ug/ml monitor bottle was read in duplicate after incubqtion for 3 hr 10 min and 3 hr 20 min. At this time if the pH was 3-2 or less the metabolism of the organi-ms was stooped bv plncine the bottles in crushed ice a-t 4'C. If the pH remained above 3-2 further incubation was carried out until the appropriate fall in pH was achieved. Triplicate samples were pooled and mixed and the pH value read at 10°C. A standard curve was constructed on linear or semi-log graph paper The growth of C. albicans produced a rapid fall in pH of the glucose/YNB medium over a period of four hours. This was dependent on the starting pH, the initial concentration of C. albicans, and the rate of growth of the organism in the liquid culture medium. These factors therefore determine the sensitivity of the method. The effect of variation in the concentration of the organism on the rate of fall of pH in the liquid culture medium is shown in fig. 1 . A concentration of at least 107 candida/ml was necessary to produce a maximum fall of pH within four hours. fig. 2 and the importance of adjusting this within narrow limits to achieve the maximum fall over the range of drug concentration measured is emphasized. In fig. 3 the standard curve is shown in four separate assays carried out over a period of two weeks. Good reproducibility is shown between separate assays. Serial dilution of test sera have shown that accurate readings are obtained at any point on the standard curve between 2 and 10 ,ug/ml. The mean value (± S.E. of mean) for a 60 ,ug/ml control serum obtained in 17 separate assays was 62-1 ± 1-7. These results were adversely affected by two results of 81 and 75 ,ug/ml which were obtained from obviously abnormal curves which in normal laboratory practice would be discarded and the assay repeated. Exclusion of these two results gives a mean value of 59*9 ± 0 8 (co-efficient of variation ± 4-8%). 
Discussion
Since 5-FC is unpredictably neutralized by cytosine and peptones (Shadomy, 1969) , it was necessary to use a synthetic culture medium to exclude these components despite the fact that such a medium does not provide optimal growth conditions for C. albicans. This, together with the longer generation time of C. albicans when compared with other organisms, introduced difficulties in achieving a rapid reproducible method. The assay was further complicated by the slowing of organism metabolism which occurs at low pH. Since tests established that 5-FC could be autoclaved without affecting its antifungal activity, all standards, control sera, and test sera were autoclaved before incorporation in the assay mixture. This had the effect of driving off dissolved blood gases thus eliminating minor differences in starting pH which might occur from this cause. Furthermore, as protein is denatured the effect of specific or non-specific antibodies which may be present in test serum and which could interfere with growth of the organism and acid production is reduced.
Provided the conditions of the assay are observed, rapid (Koechlin et al., 1966; Wade and Sudlow, 1972) . The recommended dose range in persons with normal kidney function is 0-1-0 2 g/kg/day but this has not been firmly established and there is little information about blood and urine levels of the drug. The development of a rapid microbiological assay (Schiavone et al., 1973) has allowed us to make observations on the serum levels and urinary excretion of 5-FC in normal subjects and in patients with impaired renal function.
Materials and Methods
Twenty subjects were studied of whom five had normal renal I ). Each person was studied after an oral dose of 2 g 5-FC. Serum and urine 5-FC measurements were made as previously described (Schiavone et al., 1973) . Serum levels of 5-FC were measured often over 12 hours in normal subjects and for up to 48 hours in patients with renal failure. In most subjects accurately timed urine collections were also obtained for calculation of 5-FC and creatinine clearances, and in four patients the removal of 5-FC was studied during haemodialysis.
The serum 5-FC levels (log scale) were plotted on semilogarithmic paper against time. After the first four hours the fall in serum 5-FC was about linear in all subjects and the biological, half life (tj) of the drug was calculated from the linear regression of log serum 5-FC against time. The volume of distribution of the drug was calculated by extrapolating this curve to zero time and dividing the total dose by the derived value for the serum 5-FC concentration at zero time. Clearances of 5-FC and creatinine were determined from a timed urine collection (usually the four-to eight-hour period after the dose) and the mean serum concentration for the collection period.
The assumption was made that the drug was not bound to protein (Wade and Sudlow, 1972 fig. 1 over 12 hours after an oral dose of 2 g 5-FC in five normal subjects and in five patients with severe terminal renal failure (creatinine clearance <3 ml/min). When renal function was normal a mean peak level (± S.E. of mean) of
